Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.72 USD | +0.81% | +5.06% | -36.44% |
Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 76.49M | Sales 2025 * | 164M 109M | Capitalization | 344M 228M |
---|---|---|---|---|---|
Net income 2024 * | -56M -37.14M | Net income 2025 * | -17M -11.28M | EV / Sales 2024 * | 2.81 x |
Net cash position 2024 * | 19.8M 13.13M | Net cash position 2025 * | 1.85M 1.23M | EV / Sales 2025 * | 2.09 x |
P/E ratio 2024 * |
-6.36
x | P/E ratio 2025 * |
-32.1
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on AVITA Medical, Inc.
1 day | +0.81% | ||
1 week | +5.06% | ||
Current month | +3.81% | ||
1 month | -42.71% | ||
3 months | -48.40% | ||
6 months | -17.50% | ||
Current year | -36.44% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +2.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 8.72 | +0.81% | 188,446 |
24-05-01 | 8.65 | +2.98% | 185,248 |
24-04-30 | 8.4 | -3.67% | 145,172 |
24-04-29 | 8.72 | +2.35% | 189,868 |
24-04-26 | 8.52 | +2.65% | 285,980 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.44% | 225M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+48.20% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- RCEL Stock